{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:58:38Z","timestamp":1789955918698,"version":"4.0.1"},"reference-count":135,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cidjournal.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.clindermatol.2015.11.003","type":"journal-article","created":{"date-parts":[[2015,11,22]],"date-time":"2015-11-22T06:34:01Z","timestamp":1448174041000},"page":"183-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Cutaneous and ocular manifestations of neurocutaneous syndromes"],"prefix":"10.1016","volume":"34","author":[{"given":"Karen A.","family":"Chernoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie V.","family":"Schaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2015.11.003_bb0005","series-title":"Embryology of neurocutaneous syndromes: role of neural crest. In: Neurocutaneous Syndromes during Development","author":"Sarnat","year":"2005"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0010","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/08830738050200080101","article-title":"Embryology of the neural crest: its inductive role in the neurocutaneous syndromes","volume":"20","author":"Sarnat","year":"2005","journal-title":"J Child Neurol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0015","series-title":"The Neural Crest","author":"Le Dourarin","year":"1999"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0020","series-title":"The Neural Crest in Development and Evolution","author":"Hall","year":"1999"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0025","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/jmg.26.11.704","article-title":"A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity","volume":"26","author":"Huson","year":"1989","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0030","first-page":"67","article-title":"Neurofibromatosis. A clinical and genetic study of 96 cases in Gothenburg, Sweden","volume":"96","author":"Samuelsson","year":"1981","journal-title":"Acta Derm Venereol Suppl"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0035","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0888-7543(87)90043-7","article-title":"Linkage of NF1 to 12 chromosome 17 markers: a summary of eight concurrent reports","volume":"1","author":"Skolnick","year":"1987","journal-title":"Genomics"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0040","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/346696a0","article-title":"Oncoproteins. GAPs in understanding Ras","volume":"346","author":"Wigler","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0045","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/neu.480270408","article-title":"Regulated expression of neurofibromin in migrating neural crest cells of avian embryos","volume":"27","author":"Stocker","year":"1995","journal-title":"J Neurobiol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0050","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1086\/519562","article-title":"Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1","volume":"81","author":"Maertens","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0055","series-title":"National Institutes of Health Consensus Development Conference Statement: Neurofibromatosis. Bethesda, Md., USA, July 13-15, 1987","first-page":"172","volume":"1","year":"1988"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0060","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1542\/peds.105.3.608","article-title":"Use of the National Institutes of Health criteria for diagnosis of neurofibromatosis 1 in children","volume":"105","author":"DeBella","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0065","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1399-0004.2011.01801.x","article-title":"Valuing gene testing in children with possible neurofibromatosis 1","volume":"82","author":"Tsang","year":"2012","journal-title":"Clin Genet"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0070","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/cge.12187","article-title":"A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the Netherlands","volume":"85","author":"Van Minkelen","year":"2014","journal-title":"Clin Genet"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0075","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/jmedgenet-2013-101648","article-title":"Can the diagnosis of NF1 be excluded clinically? A lack of pigmentary findings in families with spinal neurofibromatosis demonstrates a limitation of clinical diagnosis","volume":"50","author":"Burkitt Wright","year":"2013","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0080","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/archdermatol.2009.169","article-title":"Predictive value of caf\u00e9 au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1","volume":"145","author":"Nunley","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0085","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000327379","article-title":"Evolving pattern with age of cutaneous signs in neurofibromatosis type 1: a cross-sectional study of 728 patients","volume":"222","author":"Duong","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2008.12.051","article-title":"Neurofibromatosis type 1","volume":"61","author":"Boyd","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0095","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00403-006-0644-6","article-title":"Caf\u00e9-au-lait spots in neurofibromatosis type 1 and in healthy control individuals: hyperpigmentation of a different kind?","volume":"297","author":"De Schepper","year":"2006","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0100","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0190-9622(99)70075-7","article-title":"The diagnostic value of caf\u00e9-au-lait macules","volume":"40","author":"Landau","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0105","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00431-011-1418-5","article-title":"LEOPARD syndrome (PTPN11, T468 M) in three boys fulfilling neurofibromatosis type 1 clinical criteria","volume":"170","author":"Carcavilla","year":"2011","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0110","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/pbc.24254","article-title":"Optic pathway glioma as part of a constitutional mismatch-repair deficiency syndrome in a patient meeting the criteria for neurofibromatosis type 1","volume":"60","author":"Yeung","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0115","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1001\/jama.2009.1663","article-title":"Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome","volume":"302","author":"Messiaen","year":"2009","journal-title":"JAMA"},{"issue":"A","key":"10.1016\/j.clindermatol.2015.11.003_bb0120","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/ajmg.a.35297","article-title":"Caf\u00e9-au-lait macules and intertriginous freckling in piebaldism: clinical overlap with neurofibromatosis type 1 and Legius syndrome","volume":"158","author":"Stevens","year":"2012","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0125","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00439-008-0542-4","article-title":"Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg?","volume":"124","author":"Wimmer","year":"2008","journal-title":"Hum Genet"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0130","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1101\/gad.190876.112","article-title":"A shared molecular mechanism underlies the human rasopathies Legius syndrome and neurofibroamtosis-1","volume":"26","author":"Stowe","year":"2012","journal-title":"Genes Dev"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0135","first-page":"180","article-title":"Blue-red macules and pseudoatrophic macules in neurofibromatosis 1","volume":"129","author":"Zeller","year":"2002","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood-2009-09-242875","article-title":"Mast cells and the neurofibroma microenvironment","volume":"116","author":"Staser","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0145","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0190-9622(95)91325-4","article-title":"Neurocutaneous syndromes associated with pigmentary skin lesions","volume":"32","author":"Zvulunov","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0150","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jaad.2006.11.022","article-title":"Pigmented plexiform neurofibroma: distrinction from a large congenital melanocytic nevus","volume":"56","author":"Schaffer","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0155","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/ICU.0b013e3283570127","article-title":"Type I, neurofibromatosis: a geno-oculo-dermatologic update","volume":"23","author":"Schnur","year":"2012","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0160","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/jmg.2009.073965","article-title":"Diagnosis, management and complications of glomus tumours of the digits in neurofibromatosis type 1","volume":"47","author":"Stewart","year":"2010","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0165","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.1158\/0008-5472.CAN-09-1752","article-title":"Glomus tumors in neurofibromatosis type 1: genetic, functional, and clinical evidence of a novel association","volume":"69","author":"Brems","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0170","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/jamadermatol.2013.6434","article-title":"Juvenile xanthogranuloma and nevus anemicus in the diagnosis of neurofibromatosis type 1","volume":"150","author":"Ferrari","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0175","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jaad.2013.06.039","article-title":"Nevus anemicus in neurofibromatosis type 1: a potential new diagnostic criterion","volume":"69","author":"Marque","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0180","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.jhsa.2013.05.025","article-title":"The association between glomus tumors and neurofibromatosis","volume":"38","author":"Harrison","year":"2013","journal-title":"J Hand Surg [Am]"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.0736-8046.2004.21201.x","article-title":"Juvenile xanthogranuloma associated with neurofibromatosis 1: 14 patients without evidence of hematologic malignancies","volume":"21","author":"Cambiaghi","year":"2004","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0190","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3928\/0191-3913-20030901-11","article-title":"Characteristics of Lisch nodules in patients with neurofibromatosis type 1","volume":"40","author":"Nichols","year":"2003","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0195","first-page":"342","article-title":"Lisch nodules of the iris in neurofibromatosis type 1","volume":"18","author":"Richetta","year":"2004","journal-title":"JEADV"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0200","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/13816819109023079","article-title":"Structure of Lisch nodules in neurofibromatosis type 1","volume":"12","author":"Williamson","year":"1991","journal-title":"Ophthalmic Paediatr Genet"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0205","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0022-3476(89)80137-4","article-title":"Optic gliomas in children with neurofibromatosis type 1","volume":"114","author":"Listernick","year":"1989","journal-title":"J Pediatr"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0210","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ana.21107","article-title":"Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations","volume":"61","author":"Listernick","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0215","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/08830738030180070401","article-title":"Optic pathway gliomas in children with and without neurofibromatosis 1","volume":"18","author":"Czyzyk","year":"2003","journal-title":"J Child Neurol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0220","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archpedi.1985.02140130035025","article-title":"Precocious puberty associated with neurofibromatosis and optic gliomas","volume":"139","author":"Laue","year":"1985","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0225","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00431-013-2035-2","article-title":"Ophthalmological assessment of children with neurofibromatosis type 1","volume":"172","author":"Cassiman","year":"2013","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0230","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1001\/jamaophthalmol.2013.5819","article-title":"Marked recovery of vision in children with optic pathway gliomas treated with bevacizumab","volume":"132","author":"Avery","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0235","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0140-6736(00)02716-1","article-title":"Frequency of choroidal abnormalities in neurofibromatosis type 1","volume":"356","author":"Yasunari","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0240","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ophtha.2011.07.046","article-title":"Choroidal abnormalities detected by near-infrared reflectance imaging as new diagnostic criterion for neurofibromatosis 1","volume":"119","author":"Viola","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0245","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jamaophthalmol.2013.6281","article-title":"Retinal vasoproliferative tumors in 6 patients with neurofibromatosis type 1","volume":"132","author":"Shields","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0250","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.spen.2006.01.006","article-title":"Cognitive profile of neurofibromatosis type 1","volume":"13","author":"Levine","year":"2006","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0255","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/jmg.2006.045906","article-title":"Guidelines for the diagnosis and management of individuals with neurofibromatosis 1","volume":"44","author":"Ferner","year":"2007","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0260","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1542\/peds.2007-3204","article-title":"Neurofibromatosis type 1 revisited","volume":"123","author":"Williams","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0265","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cell.2008.08.041","article-title":"Nf1-dependent tumors require a microenvironment containing Nf1 +\/-- and c-kit dependent bone marrow","volume":"135","author":"Yang","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0270","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S1470-2045(12)70414-X","article-title":"Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: A phase 2 trial","volume":"13","author":"Robertson","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0275","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI60578","article-title":"MEK inhibition exhibits efficacy in human and mouse meurofibromatosis tumors","volume":"123","author":"Jessen","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0280","first-page":"318","article-title":"Prevalence of tuberous sclerosis estimated by capture-recapture analysis","volume":"352","author":"O\u2019Callaghan","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0285","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","article-title":"Epidemiology of tuberous sclerosis","volume":"615","author":"Osborne","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0290","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/316951","article-title":"Mutational analysis in a cohort of 224 tuberous sclerosis patients indicated increased severity of TSC2, compared with TSC1, disease in multiple organs","volume":"68","author":"Dabora","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0295","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0300","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.braindev.2008.09.013","article-title":"Recent advances in neurobiology of tuberous sclerosis complex","volume":"31","author":"Napolioni","year":"2009","journal-title":"Brain Dev"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0305","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2165\/11207730-000000000-00000","article-title":"Everolimus: in patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex","volume":"14","author":"Curran","year":"2012","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0310","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archneur.55.3.379","article-title":"Poor mental development in patients with tuberous sclerosis complex: clinical risk factors","volume":"55","author":"J\u00f3\u017awiak","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0315","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1749-6632.1991.tb37745.x","article-title":"History and significance of white macules, earliest visible sign of tuberous sclerosis","volume":"615","author":"Fitzpatrick","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0320","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/bjo.85.4.420","article-title":"Ophthalmic manifestations of tuberous sclerosis: a population based study","volume":"85","author":"Rowley","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0325","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archopthalmol.2011.1707","article-title":"Retinal pigment epithelial depigmented lesions associated with tuberous sclerosis complex","volume":"130","author":"Shields","year":"2012","journal-title":"Arch Opththalmol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0330","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3928\/0191-3913-19811101-12","article-title":"Iris and fundus pigmentary changes in tuberous sclerosis","volume":"18","author":"Lucchese","year":"1981","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0335","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0340","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jaad.2009.08.042","article-title":"Acral lesions in tuberous sclerosis complex: insights into pathogenesis","volume":"63","author":"Aldrich","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.1996.tb03597.x","article-title":"The cutaneous features of tuberous sclerosis: a population study","volume":"135","author":"Webb","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0350","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jaad.2006.11.019","article-title":"Oral findings in 58 adults with tuberous sclerosis complex","volume":"56","author":"Sparling","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0355","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1749-6632.1991.tb37783.x","article-title":"Enamel pitting. A common sign of tuberous sclerosis","volume":"615","author":"Mlynarczyk","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0360","series-title":"Tuberous Sclerosis Complex","first-page":"145","article-title":"Ophthalmic findings","author":"Robertson","year":"1999"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0365","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.ophtha.2012.03.020","article-title":"Tuberous sclerosis complex: genotype\/phenotype correlation of retinal findings","volume":"119","author":"Aronow","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0370","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","article-title":"Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Krueger","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0375","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicenter, randomised, double-blind, placebo-control trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0380","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0385","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0390","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicenter, randomised, placebo-controlled phase 3 trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0395","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2133.2008.08677.x","article-title":"The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis","volume":"159","author":"Hofbauer","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0400","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2165\/11634580-000000000-00000","article-title":"Topical rapamycin therapy to alleviate the cutaneous manifestations of tuberous sclerosis complex: a double-blind, randomized, controlled trial to evaluate the safety and efficacy of topically applied rapamycin","volume":"12","author":"Koenig","year":"2012","journal-title":"Drugs R D"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0405","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/bjd.12567","article-title":"First left-right comparative study of topical rapamycin vs. vehicle for facial angiofibromas in patients with tuberous sclerosis complex","volume":"169","author":"Tanaka","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0410","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1001\/archderm.148.1.138","article-title":"A novel application of topical rapamycin formulation, an inhibitor of mTOR, for patients with hypomelanotic macules in tuberous sclerosis complex","volume":"148","author":"Wataya-Kaneda","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0415","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/ajd.12125","article-title":"Topical rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: follow up of a pilot study and promising future directions","volume":"55","author":"Tu","year":"2014","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0420","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ajhg.2012.10.021","article-title":"Germline PIK3 CA and AKT1 mutations in Cowden and Cowden-like syndromes","volume":"92","author":"Orloff","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0425","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0","article-title":"Mutations of the human PTEN gene","volume":"16","author":"Bonneau","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0430","first-page":"4183","article-title":"Somatic mutations of PTEN in glioblastoma multiforme","volume":"57","author":"Wang","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0435","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/jnci\/93.16.1246","article-title":"PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme","volume":"93","author":"Smith","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0440","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1215\/15228517-4-3-196","article-title":"Pten signaling in gliomas","volume":"4","author":"Knobbe","year":"2002","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0445","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1126\/science.1065518","article-title":"Negative regulation of neural stem\/progenitor cell proliferation by the PTEN tumor suppressor gene in vivo","volume":"294","author":"Groszer","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0450","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/jnci\/djt277","article-title":"Cowden Syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria","volume":"105","author":"Pilarski","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0455","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ajhg.2010.11.013","article-title":"A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands","volume":"88","author":"Tan","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0460","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/archderm.142.5.625","article-title":"Mucocutaneous neuromas","volume":"142","author":"Schaffer","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0465","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ctrv.2010.04.002","article-title":"Cowden syndrome","volume":"36","author":"Farooq","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0470","series-title":"Pediatric Opthalmology and Strabismus","year":"2003"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0475","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jaad.2005.06.022","article-title":"Clinical and histopathological findings in Bannayan-Riley-Ruvalcaba syndrome","volume":"53","author":"Erkek","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0480","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","article-title":"Lifetime cancer risks in individuals with germline PTEN mutations","volume":"18","author":"Tan","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0485","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1002\/ajmg.a.36266","article-title":"PTEN hamartoma tumor syndromes in childhood: description of two cases and a proposal for follow-up protocol","volume":"161A","author":"Piccione","year":"2013","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0490","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/pr.2013.246","article-title":"Sirolimus treatment of severe PTEN hamartoma tumor syndrome: case report and in vitro studies","volume":"75","author":"Schmid","year":"2014","journal-title":"Pediatr Res"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0495","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/pbc.23098","article-title":"Oral rapamycin in the treatment of patients with hamartoma syndromes and PTEN mutation","volume":"57","author":"Iacobas","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0500","first-page":"48","article-title":"Facial port-wine stains and Sturge-Weber syndrome","volume":"76","author":"Enrolras","year":"1985","journal-title":"Pediatrics"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0505","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1542\/peds.87.3.323","article-title":"Location of port-wine stains and the likelihood of ophthalmic and\/or central nervous system complications","volume":"87","author":"Tallman","year":"1991","journal-title":"Pediatrics"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0510","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jaad.2006.05.066","article-title":"Vascular malformations. Part II: Associated syndromes","volume":"56","author":"Garzon","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0515","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.ophtha.2011.04.022","article-title":"Periorcular port wine stain: the great Ormond street hospital experience","volume":"118","author":"Khaier","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0520","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.bjps.2007.05.011","article-title":"Facial port-wine stains\u2014clinical stratification and risks of neuro-ocular involvement","volume":"61","author":"Ch\u2019ng","year":"2008","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0525","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1089\/lrb.2007.1016","article-title":"Update on Sturge-Weber syndrome: diagnosis, treatment, quantitative measures, and controversies","volume":"5","author":"Comi","year":"2007","journal-title":"Lymphat Res Biol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0530","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1525-1470.2011.01485.x","article-title":"Sturge-Weber syndrome in patients with facial port-wine stain","volume":"29","author":"Piram","year":"2012","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0535","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1056\/NEJMoa1213507","article-title":"Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ","volume":"368","author":"Shirley","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0540","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature07586","article-title":"Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi","volume":"457","author":"Van Raamsdonk","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0545","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/archophthalmol.2011.135","article-title":"Phacomatosis pigmentovascularis of cesioflammea type in 7 patients: combination of ocular pigmentation (melanocytosis or melanosis) and nevus flammeus with risk for melanoma","volume":"129","author":"Shields","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0550","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jaad.2011.11.964","article-title":"Investigation into optimal treatment intervals of facial port-wine stains using the pulsed dye laser","volume":"67","author":"Anolik","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0555","first-page":"48","article-title":"Facial port-wine stains and Sturge-Weber syndrome","volume":"76","author":"Enjolras","year":"1985","journal-title":"Pediatrics"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0560","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jaapos.2009.04.007","article-title":"Port-wine vascular malformations and glaucoma risk in Sturge-Weber syndrome","volume":"13","author":"Sharan","year":"2009","journal-title":"J AAPOS"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0565","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1091-8531(99)70093-5","article-title":"Glaucoma in Sturge-Weber syndrome","volume":"3","author":"Awad","year":"1999","journal-title":"J AAPOS"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0570","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1001\/jamaophthalmol.2013.4044","article-title":"Increased choroidal thickness in patients with Sturge-Weber syndrome","volume":"131","author":"Arora","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0575","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ohc.2004.07.004","article-title":"Choroidal hemangiomas","volume":"18","author":"Singh","year":"2005","journal-title":"Ophthalmol Clin N Am"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0580","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jaapos.2011.09.014","article-title":"The role of episcleral venous pressure in glaucoma associated with Sturge-Weber syndrome","volume":"16","author":"Shiau","year":"2012","journal-title":"J AAPPOS"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0585","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1212\/01.WNL.0000035639.54567.5C","article-title":"Outcomes of 32 hemispherectomies for Sturge-Weber syndrome worldwide","volume":"59","author":"Kossoff","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0590","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1469-8749.2011.04169.x","article-title":"Updates and future horizons on the understanding, diagnosis, and treatment of Sturge-Weber syndrome brain involvement","volume":"54","author":"Lo","year":"2012","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0595","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejpn.2013.10.003","article-title":"Sturge-Weber syndrome: from the past to the present","volume":"18","author":"Sudarsanam","year":"2014","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0600","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0883073812463607","article-title":"Aspirin use in Sturge-Weber syndrome: side effects and clinical outcomes","volume":"28","author":"Lance","year":"2013","journal-title":"J Child Neurol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0605","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s11940-013-0253-6","article-title":"Sturge-Weber syndrome","volume":"15","author":"Bachur","year":"2013","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0610","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0190-9622(91)70115-I","article-title":"Neurocutaneous melanosis: definition and review of the literature","volume":"24","author":"Kadonga","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0615","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/jid.2013.146","article-title":"Making a mountain out of a molehill: NRAS, mosaicism, and large congenital nevi","volume":"133","author":"Gerami","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0620","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1038\/jid.2013.70","article-title":"Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS","volume":"133","author":"Kinsler","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0625","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jaad.2005.10.040","article-title":"Large or multiple congenital melanocytic nevi: occurrence of neurocutaneous melanocytosis in 1008 persons","volume":"54","author":"Bett","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0630","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/archderm.140.2.171","article-title":"Number of satellite nevi as a correlate for neurocutaneous melanocytosis in patients with large congenital melanocytic nevi","volume":"140","author":"Marghoob","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0635","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/13816810490498206","article-title":"Fundus features of a case of neurocutaneous melanosis","volume":"25","author":"Kiratli","year":"2004","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0640","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jaad.2007.09.029","article-title":"SCALP syndrome: sebaceous nevus syndrome, CNS malformations, aplasia cutis congenita, limbal dermoid, and pigmented nevus (giant congenital melanocytic nevus) with neurocutaneous melanosis: a distinct syndromic entity","volume":"58","author":"Lam","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0645","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.clinimag.2013.10.001","article-title":"Neurocutaneous melanosis in children with giant congenital nevi","volume":"38","author":"Bekiesinska-Figatowska","year":"2014","journal-title":"Clin Imaging"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0650","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1469-8749.2012.04275.x","article-title":"Spectrum of central nervous system abnormalities in neurocutaneous melanosis","volume":"54","author":"Ramaswamy","year":"2012","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0655","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1046\/j.1525-1470.2001.01961.x","article-title":"Cerebral mass due to neurocutaneous melanosis: eight years later","volume":"18","author":"Schaffer","year":"2001","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0660","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1365-2133.2008.08775.x","article-title":"Complications of congenital melanocytic naevi in children: analysis of 16 years\u2019 experience and clinical practice","volume":"159","author":"Kinsler","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0665","doi-asserted-by":"crossref","first-page":"9339","DOI":"10.1097\/00006534-200104010-00005","article-title":"Giant congenital melanocytic nevi: the significance of neurocutaneous melanosis in neurologically asymptomatic children","volume":"107","author":"Foster","year":"2001","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0670","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.clindermatol.2010.04.004","article-title":"Congenital melanocytic nevi-when to worry and how to treat: facts and controversies","volume":"28","author":"Price","year":"2010","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.003_bb0675","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1073\/pnas.1216013110","article-title":"Combined targeting of MEK and PI3 K\/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo","volume":"110","author":"Posch","year":"2013","journal-title":"Proc Natl Acad Sci"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X15002175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X15002175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T16:19:22Z","timestamp":1718209162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X15002175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":135,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0738081X15002175"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2015.11.003","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous and ocular manifestations of neurocutaneous syndromes","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2015.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}